A study to evaluate the impact of admission hyperglycaemia on in hospital mortality and morbidity in non diabetic AMI patients

Author : Varun Bafna, Mukul Bafna, Siddhi Sancheti, Rhea Jacob, Yuvraj Sawant, Arjun Ananthanarayan

Abstract : Background: To evaluate the impact of admission hyperglycemia on in-hospital mortality and morbidity in non-diabetic AMI patients. Materials and Methods: This study was conducted on 70 non-diabetic AMI patients. Patients were categorized based on admission glucose levels into normoglycemic, mild hyperglycemia, and severe hyperglycemia groups. In-hospital mortality, major adverse cardiovascular events (MACE), and length of stay were analyzed. Results: Severe hyperglycemia was associated with significantly higher in-hospital mortality (18%) compared to mild hyperglycemia (4%) and normoglycemia (2%). The incidence of MACE, including heart failure and arrhythmias, was also higher in the severe hyperglycemia group. A dose-dependent relationship was observed between admission glucose levels and adverse outcomes. Conclusion: Admission hyperglycemia is a significant prognostic factor in non-diabetic AMI patients, with severe hyperglycemia linked to increased mortality and morbidity. Early detection and management of hyperglycemia are essential for improving patient outcomes.

Keywords : Hyperglycemia, non-diabetic AMI, outcomes.

Conference Name : International Conference on Oncology, Cardiology and Critical Care (ICOCCC-26)

Conference Place : Mumbai, India

Conference Date : 29th Mar 2026